UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-K/A
Amendment No. 1
[X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE
SECURITIES EXCHANGE ACT OF 1934
[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE
SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended Commission File No.
December 31, 1996 0-15443
THERAGENICS CORPORATION
(Exact name of registrant as specified in its charter)
Delaware 58-1528626
(State of incorporation) (I.R.S. Employer Identification Number)
5325 Oakbrook Parkway
Norcross, Georgia 30093
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code:(770) 381-8338
Securities registered pursuant to Section 12(b) of the Act:
Title of each class Name of each exchange on which registerer
None None
Securities registered pursuant to Section 12(g) of the Act:
Title of Class
Common Stock, par value $.01 per share, together with the associated
Common Stock Purchase Rights
Indicate by check mark whether the registrant (1) has filed
all reports required to be filed by Section 13 or 15(d) of the
Securities Exchange Act of 1934 during the preceding 12 months
(or for such shorter period that the registrant was required to
file such reports), and (2) has been subject to such filing
requirements for the past 90 days. YES X NO
Indicate by check mark if disclosure of delinquent filers
pursuant to Item 405 of Regulation S-K is not contained herein and
will not be contained, to the best of registrant's knowledge, in
definitive proxy or information statements incorporated by reference
in Part III of this Form 10-K or any amendment to
this Form 10-K _____.
As of March 18, 1997 the aggregate market value of the common
stock of the registrant held by non-affiliates of the registrant,
as determined by reference to the closing price of the Common
Stock as reported on the Nasdaq National Market system, was
$244,272,249.
<PAGE>
As of March 18, 1997 the number of shares of common stock,
$.01 par value, outstanding was 11,843,503.
Documents incorporated by Reference: Proxy Statement for the
registrant's 1997 Annual Meeting of Stockholders, to be filed with
the Securities and Exchange Commission not later than 120 days after
December 31, 1996, is incorporated by reference in Part III
herein.
<PAGE>
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned, thereunto duly authorized.
THERAGENICS CORPORATION
(Registrant)
By:/s/ M. Christine Jacobs
M. Christine Jacobs
Chief Executive Officer
Dated: March 24, 1997
Norcross, Georgia
Pursuant to the requirements of the Securities Exchange Act of 1934, this
report has been signed below by the following persons on behalf of the
registrant and in the capacities and on the dates indicated.
Name Title Date
/s/ M. Christine Jacobs Chief Executive Officer 3/24/97
M. Christine Jacobs (Principal Executive Officer);
Director
/s/ Bruce W. Smith Chief Financial Officer, 3/24/97
Bruce W. Smith Treasurer (Principal
Financial Officer) and
Secretary
/s/ Charles Klimkowski Director, Chairman 3/24/97
Charles Klimkowski
/s/ John V. Herndon Director 3/24/97
John V. Herndon
/s/ Orwin L. Carter Director 3/24/97
Orwin L. Carter
/s/ Peter A.A. Saunders Director 3/24/97
Peter A.A. Saunders
/s/ Otis W. Brawley Director 3/24/97
Otis W. Brawley
<PAGE>
THERAGENICS CORPORATION
INDEX TO EXHIBITS
Page No.
10.17 Employment Agreement of M. Christine 53
Jacobs dated as of August 1, 1996
24.1 Consent of Independent Public Accountants 73
for Incorporation by Regerence of Audit
Statement into Registration Statement
(CORRECTED CONSENT DATE)
Exhibit 24.1
CONSENT OF INDEPENDENT CERTIFIED PUBLIC ACCOUNTANTS
Board of Directors
Theragenics Corporation
We hereby consent to the incorporation by reference of our report dated January
16, 1997, appearing in your Annual Report on form 10-K for the year ended
December 31, 1996, in the Company's Registration Statement on Form S-8, file
numbers 333-15313 and 33-40737.
GRANT THORNTON LLP
Alanta, Georgia
March 24, 1997
